2021
DOI: 10.1016/j.dnarep.2021.103203
|View full text |Cite
|
Sign up to set email alerts
|

Targeting Wee1 kinase as a therapeutic approach in Hematological Malignancies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
16
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 42 publications
(19 citation statements)
references
References 166 publications
1
16
0
Order By: Relevance
“…Innovative molecular therapy also aims to target leukemic cells' vulnerabilities more precisely. The use of conventional DNA-damage-based chemotherapy drugs in the past decades and the understanding of molecular mechanisms led to the discovery of potential new targets (e.g., WEE1 kinase) [38].…”
Section: Discussionmentioning
confidence: 99%
“…Innovative molecular therapy also aims to target leukemic cells' vulnerabilities more precisely. The use of conventional DNA-damage-based chemotherapy drugs in the past decades and the understanding of molecular mechanisms led to the discovery of potential new targets (e.g., WEE1 kinase) [38].…”
Section: Discussionmentioning
confidence: 99%
“…A study in Iraq reported nearly similar results, where the resistant rates for penicillin antibiotics including ticarcillin, piperacillin and minocycline and trimethoprim+ sulfamthoxazole were 76.7%, 81.0%, 91.0% and 93.5%, respectively (26). Also, Abdul-Wahid, (24,(40)(41)(42)(43)(44)(45)(46)(47)(48)(49)(50)(51) in Iraq reported similar results where the resistant rates for ceftazidime, cefepime, ciprofloxacin, pefloxacin, gentamicin and aztreonam (64.0%, 63.5%, 59.0%, 58.5%, 63.0% and 57.0%), respectively. While, the other study in Iraq by Alkazrage (27) reported the resistant rates for imipenem, meropenem and colistin (35.0%, 31.0% and 21.8%), respectively.…”
Section: Discussionmentioning
confidence: 71%
“…A study in Iraq reported nearly similar results, where the resistant rates for penicillin antibiotics including ticarcillin, piperacillin and minocycline and trimethoprim+ sulfamthoxazole were 76.7%, 81.0%, 91.0% and 93.5%, respectively (26). Also, Abdul-Wahid, (24,(40)(41)(42)(43)(44)(45)(46)(47)(48)(49)(50)(51) in Iraq reported similar results where the resistant rates for ceftazidime, cefepime, ciprofloxacin, pefloxacin, gentamicin and aztreonam (64.0%, 63.5%, 59.0%, 58.5%, 63.0% and 57.0%), respectively. While, the other study in Iraq by Alkazrage ( 27) reported the resistant rates for imipenem, meropenem and colistin (35.0%, 31.0% and 21.8%), respectively.…”
Section: Discussionmentioning
confidence: 81%